recombinant human bone morphogenic protein 2
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for recombinant human bone morphogenic protein 2, covering 2021-12-02 to 2021-12-02. Get the full timeline:
Most recent: Clinical Trial Update: Lateral Ridge Augmentation Using Autogenous Bone Blocks or Xenogenic Bone Block Grafts Loaded With Recombinant Human Bone Morphogenic Protein 2 [Phase 3]